Boyu, Sinopharm among shortlisted bidders for drugmaker Mundipharma's China unit

Boyu, Sinopharm among shortlisted bidders for drugmaker Mundipharma's China unit

Photo: National Cancer Institute / Unsplash

08 June, 2021

Boyu Mundipharma Sinopharm

Printed by Unregistered user on Wed, 24 Dec 2025 22:03:44 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Sackler-owned Mundipharma kicks of sale of China unit for up to $1b

Singapore: Mundipharma eyes acquisition of product brands for SE Asia push

Read more from Greater China

Global investors bet on Chinese AI as Wall Street fears bubble

Viewpoint: Hong Kong IPO market eyes continued recovery after comeback year 2025